Operating
Stock-Based Comp
Elevance Health Stock-Based Comp increased by 83.3% to $55.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 32.1%, from $81.00M to $55.00M. Over 3 years (FY 2021 to FY 2025), Stock-Based Comp shows relatively stable performance with a 2.7% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026Apr 22, 2026
How to read this metric
Increasing levels may indicate a focus on talent retention but can also signal potential shareholder dilution.
Detailed definition
This represents the value of equity-based awards granted to employees as part of their total compensation package. Since...
Peer comparison
Standard across large-cap corporations; varies based on corporate compensation philosophy.
Metric ID:
stock_based_compensationHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $69.00M | $63.00M | $59.00M | $50.00M | $72.00M | $69.00M | $73.00M | $61.00M | $78.00M | $78.00M | $72.00M | $62.00M | $92.00M | $66.00M | $81.00M | $81.00M | $84.00M | $30.00M | $55.00M |
| QoQ Change | — | -8.7% | -6.3% | -15.3% | +44.0% | -4.2% | +5.8% | -16.4% | +27.9% | +0.0% | -7.7% | -13.9% | +48.4% | -28.3% | +22.7% | +0.0% | +3.7% | -64.3% | +83.3% |
| YoY Change | — | — | — | — | +4.3% | +9.5% | +23.7% | +22.0% | +8.3% | +13.0% | -1.4% | +1.6% | +17.9% | -15.4% | +30.6% | -12.0% | +27.3% | — | -32.1% |
Range$30.00M – $92.00M
CAGR-4.9%
Avg YoY Growth+7.0%
Median YoY Growth+8.9%
Stock-Based Comp at Other Companies
Frequently Asked Questions
- What is Elevance Health's stock-based comp?
- Elevance Health (ELV) reported stock-based comp of $55.00M in Q1 2026.
- How has Elevance Health's stock-based comp changed year-over-year?
- Elevance Health's stock-based comp decreased by 32.1% year-over-year, from $81.00M to $55.00M.
- What is the long-term trend for Elevance Health's stock-based comp?
- Over 3 years (2021 to 2025), Elevance Health's stock-based comp has grown at a 2.7% compound annual growth rate (CAGR), from $255.00M to $276.00M.
- What does stock-based comp mean?
- The non-cash cost of paying employees with company stock instead of cash.